Mirikizumab – the first anti-IL23 p19 antibody in ulcerative colitis therapy
Drug profileGastroent Hepatol 2024; 78(1): 27–30. doi: 10.48095/ccgh202427
Literaturepdf Milan LukášFirst Congress of the Benin Society of Hepato-Gastroenterology
Congress reportGastroent Hepatol 2023; 77(6): 551–552.
pdf Vincent ZoundjiekponPancreatic cancer surveillance in high-risk individuals Position statement of professional societies
StanoviskoGastroent Hepatol 2023; 77(6): 529–538. doi: 10.48095/ccgh2023529
LiteraturepdfNew perspectives in bariatric-metabolic treatment
Review articleGastroent Hepatol 2023; 77(6): 524–528. doi: 10.48095/ccgh2023524
SummaryLiteraturepdf Martin FriedSwitch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study
Original articleGastroent Hepatol 2023; 77(4): 336–341. doi: 10.48095/ccgh2023336
SummaryLiteraturepdf Jindra Reissigová, Karin Černá , Milan Lukáš jr., Milan Lukáš, Veronika Hrubá, Naděžda Machková, Dana Ďuricová, Martin Kolář, Kateřina Vlková, Lea ČermákováChanging epidemiology of Clostridioides difficile infection – increasing number of community-acquired forms and infections in children
Review articleGastroent Hepatol 2023; 77(4): 315–321. doi: 10.48095/ccgh2023315
SummaryLiteraturepdf Robert Rosoľanka, Martin Schnierer, Martin Sučík, Katarína Šimeková, Peter BánovčinImpact of the COVID-19 pandemic on acute pancreatitis in the Czech Republic – pilot data PANACOTA study (PANcreatitis Acuta in COVid Time Analysis)
Original articleGastroent Hepatol 2023; 77(4): 307–314. doi: 10.48095/ccgh2023307
SummaryLiteraturepdf Martin Harazim, Radek Kroupa, Jiří Jarkovský, Ondřej Šanca, Tomáš Andrašina, Vladimír Procházka, Michal ŠenkyříkRobotic pancreatic surgery in a high-volume pancreatic cancer surgery center – first experience
Original articleGastroent Hepatol 2023; 77(4): 295–301. doi: 10.48095/ccgh2023295
SummaryLiteraturepdf Martin Loveček, Pavel Skalický, Dušan KlosBiofeedback assisted deep breathing training in refractory disorders of gut-brain interaction – our first experience, impressions and suggestions for further clinical practice
Original articleGastroent Hepatol 2023; 77(4): 289–294. doi: 10.48095/ccgh2023289
SummaryLiteraturepdf Peter Lipták, Ingrid Tonhajzerová, Martin Ďuriček, Zuzana Višňovcová, Nikola Ferencová, Diana Vážanová, Peter BánovčinUltra-processed food – a threat to liver health
Review articleGastroent Hepatol 2023; 77(2): 123–129. doi: 10.48095/ccgh2023123
SummaryLiteraturepdf Marek Rác, Martin Janičko, Tomáš Koller, Ľubomír Skladaný